Edition:
United Kingdom

DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Capital Market

0.73USD
19 Jul 2019
Change (% chg)

$0.05 (+7.82%)
Prev Close
$0.67
Open
$0.69
Day's High
$0.73
Day's Low
$0.69
Volume
82,714
Avg. Vol
301,940
52-wk High
$1.65
52-wk Low
$0.48

About

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY... (more)

Overall

Beta: 1.83
Market Cap(Mil.): $139.00
Shares Outstanding(Mil.): 191.30
Dividend: --
Yield (%): --

Financials

  DRRX.OQ Industry Sector
P/E (TTM): -- 97.98 34.52
EPS (TTM): -0.15 -- --
ROI: -53.45 7.77 12.69
ROE: -107.95 8.27 17.17

Earnings vs. Estimates